High Tower Advisors, LLC Capricor Therapeutics, Inc. Transaction History

High Tower Advisors, LLC

$84.5 Billion
Q3 2025

A detailed history of High Tower Advisors, LLC transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 1,200 shares of CAPR stock, worth $7,260. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,200

Previous 2,302 47.87%

Holding current value

$7,260

Previous $22,000 63.64%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 06, 2025	SELL	$5.94 - $11.42 $6,545 - $12,584	-1,102 Reduced 47.87%	1,200 $8,000
Q2 2025 Aug 11, 2025	BUY	$6.34 - $14.23 $3,170 - $7,115	500 Added 27.75%	2,302 $22,000
Q1 2025 May 12, 2025	BUY	$9.49 - $16.11 $15,184 - $25,776	1,600 Added 792.08%	1,802 $17,000
Q4 2024 Feb 07, 2025	SELL	$12.9 - $21.99 $1,341 - $2,286	-104 Reduced 33.99%	202 $2,000
Q3 2024 Nov 14, 2024	SELL	$3.56 - $15.21 $21,342 - $91,183	-5,995 Reduced 95.14%	306 $4,000
Q2 2024 Aug 13, 2024	BUY	$4.63 - $7.09 $25,002 - $38,286	5,400 Added 599.33%	6,301 $30,000
Q1 2024 May 06, 2024	BUY	$3.61 - $6.88 $3,252 - $6,198	901 New	901 $6,000
Q4 2022 Feb 08, 2023	BUY	$3.36 - $6.55 $10,083 - $19,656	3,001 Added 17.77%	19,885 $76,000
Q3 2022 Nov 09, 2022	SELL	$3.61 - $6.08 $12,992 - $21,881	-3,599 Reduced 17.57%	16,884 $102,000
Q2 2022 Aug 10, 2022	SELL	$2.89 - $4.51 $4,046 - $6,314	-1,400 Reduced 6.4%	20,483 $72,000
Q1 2022 May 12, 2022	BUY	$2.83 - $5.68 $61,928 - $124,295	21,883 New	21,883 $75,000
Q4 2021 Feb 10, 2022	SELL	$2.89 - $4.16 $155,944 - $224,473	-53,960 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$3.8 - $5.23 $181,108 - $249,261	47,660 Added 756.51%	53,960 $215,000
Q2 2021 Aug 06, 2021	SELL	$3.16 - $5.72 $18,960 - $34,320	-6,000 Reduced 48.78%	6,300 $33,000
Q1 2021 May 10, 2021	SELL	$3.63 - $7.93 $14,520 - $31,720	-4,000 Reduced 24.54%	12,300 $57,000
Q4 2020 Feb 10, 2021	BUY	$3.43 - $5.23 $20,580 - $31,380	6,000 Added 58.25%	16,300 $56,000
Q3 2020 Nov 13, 2020	SELL	$4.08 - $9.81 $11,016 - $26,487	-2,700 Reduced 20.77%	10,300 $55,000
Q2 2020 Aug 10, 2020	BUY	$1.0 - $8.5 $13,000 - $110,500	13,000 New	13,000 $59,000

Others Institutions Holding CAPR

# of Institutions

138

Shares Held

12.3M

Call Options Held

4.99M

Put Options Held

5.52M

View Full List

About CAPRICOR THERAPEUTICS, INC.

Ticker CAPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,346,200
Market Cap $147M
Description
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...

More about CAPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Capricor Therapeutics, Inc. Transaction History